Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04496908Phase 1Completed
Phase 1, randomised, open-label trial (2 arms), sponsored by ChristianaCare. Primary endpoint: Time to delivery up to 72 hours. Started Sep 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04496908.